Market revenue in 2022 | USD 78.0 million |
Market revenue in 2030 | USD 107.1 million |
Growth rate | 4% (CAGR from 2022 to 2030) |
Largest segment | Viscosupplements |
Fastest growing segment | Synthetic |
Historical data | 2016 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Allografts, Synthetic, Cell-based, Viscosupplements |
Key market players worldwide | Anika Therapeutics Inc, Vericel Corp, Baxter International Inc, Zimmer Biomet Holdings Inc, Stryker Corp, Smith & Nephew PLC, BioTissue, MiMedx Group Inc, Arthrex, AlloSource, VSY Biotechnology, Aptissen |
Key Regions: U.S. , UK , Japan , South Africa , Saudi Arabia
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to orthopedic regenerative surgical products market will help companies and investors design strategic landscapes.
Viscosupplements was the largest segment with a revenue share of 41.54% in 2022. Horizon Databook has segmented the Brazil orthopedic regenerative surgical products market based on allografts, synthetic, cell-based, viscosupplements covering the revenue growth of each sub-segment from 2016 to 2030.
The market is anticipated to grow substantially over the forecast period. High economic growth coupled with growing number of clinical trials in emerging market of Brazil is expected to serve this market as a high-impact rendering driver.
Increase in medical tourism and easy availability of advanced treatments at affordable costs are among the factors responsible for the country being one of the preferred destinations for orthopedic treatments.
Moreover, well-defined regulatory framework established by the health agency ANVISA and availability of skilled & experienced professionals are some of the major factors boosting the demand for orthobiologics in the country. In addition, government programs and broader private insurance coverage are the key drivers of the market in Brazil.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil orthopedic regenerative surgical products market , including forecasts for subscribers. This country databook contains high-level insights into Brazil orthopedic regenerative surgical products market from 2016 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account